Qawi, I <br/><br/>
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.  [electronic resource] 

 -  Current drug targets  Nov 2000 
 - 285-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1389-4501 
<br/><br/><label>Standard No.: </label>10.2174/1389450003349173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphatases--metabolism<br/>Animals<br/>Antigens, CD--metabolism<br/>Apyrase--metabolism<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Dipyridamole--pharmacology<br/>Humans<br/>Platelet Activation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Membrane Glycoproteins--drug effects<br/>Thrombosis--drug therapy